Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Ovarian Cancer Therapeutics
... by 2030, growing at a CAGR of 15.3% over the period 2023-2030. PARP Inhibitors, one of the segments analyzed in the report, is expected to record 16.5% CAGR and reach US$12.8 Billion by the end ... Read More
-
Global Dermocosmetic Market (2024 Edition): Analysis By Type (Skin Care, Hair Care), By Distribution Channel, By End-Users, By Region: Market Insights and Forecast (2020-2030)
... Dermocosmetic Market (2024 Edition)” which provides a complete analysis of the Global Dermocosmetic industry in terms of market segmentation By Type (Skin Care, Hair Care), By Distribution Channel (Supermarkets & Hypermarkets, Pharmacy and Drug Store, ... Read More
-
Unresectable Melanoma - Pipeline Insight, 2024
... picture of the Unresectable Melanoma pipeline landscape is provided, which includes the disease overview and Unresectable Melanoma treatment guidelines. The assessment part of the report embraces in-depth Unresectable Melanoma commercial assessment and clinical assessment of ... Read More
-
Asia-pacific Ophthalmic Drugs Market 2023-2030
... South Korea, Australia & New Zealand, China, ASEAN countries, and the Rest of Asia-Pacific are examined in this report. The rapidly aging population in Japan marks it as the regional leader in the field of ... Read More
-
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024
... the Uncomplicated Urinary Tract Infections market. A detailed picture of the Uncomplicated Urinary Tract Infections pipeline landscape is provided, which includes the disease overview and Uncomplicated Urinary Tract Infections treatment guidelines. The assessment part of ... Read More
-
2024 Global Cancer Immunotherapy Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
-
Actinic Keratosis - Pipeline Insight, 2024
... picture of the Actinic Keratosis pipeline landscape is provided, which includes the disease overview and Actinic Keratosis treatment guidelines. The assessment part of the report embraces in-depth Actinic Keratosis commercial assessment and clinical assessment of ... Read More
-
Acute Coronary Syndrome - Pipeline Insight, 2024
... Syndrome market. A detailed picture of the Acute Coronary Syndrome pipeline landscape is provided, which includes the disease overview and Acute Coronary Syndrome treatment guidelines. The assessment part of the report embraces in-depth Acute Coronary ... Read More
-
Acute Decompensated Heart Failure (ADHF) - Pipeline Insight, 2024
... growth prospects across the Acute Decompensated Heart Failure (ADHF) market. A detailed picture of the Acute Decompensated Heart Failure (ADHF) pipeline landscape is provided, which includes the disease overview and Acute Decompensated Heart Failure (ADHF) ... Read More
-
Acute Kidney Injury (AKI) - Pipeline Insight, 2024
... the Acute Kidney Injury (AKI) market. A detailed picture of the Acute Kidney Injury (AKI) pipeline landscape is provided, which includes the disease overview and Acute Kidney Injury (AKI) treatment guidelines. The assessment part of ... Read More
-
Tattoo Removal Market By Procedures (Laser Procedure, Surgical Procedure, Creams, Others), By End User (Hospitals, Dermatology Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... 2023 and is estimated to reach $4.0 billion by 2035, exhibiting a CAGR of 19.1% from 2024 to 2035. Tattoo removal refers to the process of eliminating or fading unwanted tattoos from the skin. Various ... Read More
-
Next Generation Sequencing Market By PRODUCT (Consumables, Platforms, Services), By APPLICATION (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized medicine, Agriculture and animal research, Others), By TECHNOLOGY (Sequencing By synthesis (SBS), Ion semiconductor sequencing (IOS), Sequencing By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035 The next generation sequencing ... Read More
-
The Worldwide Orthopedic & Spine Contract Manufacturing Market Report 2023-2030 - 13th Edition
... by In-house vs Contract Manufacturing and main OEM buyers CMOs' main customers / OEM preferred suppliers. Implants: Jabil, Tecomet, Orchid, Viant, Lisi, Avalign, Marle, Norman Noble, PCC, Paragon, Spitrex, etc. (70+ companies mentioned) Instruments: Jabil, ... Read More
-
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024
... the Acute Lymphoblastic Leukemia (ALL) market. A detailed picture of the Acute Lymphoblastic Leukemia (ALL) pipeline landscape is provided, which includes the disease overview and Acute Lymphoblastic Leukemia (ALL) treatment guidelines. The assessment part of ... Read More
-
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2024
... of present clinical development scenario and growth prospects across the Acute Renal Failure (ARF) (Acute Kidney Injury) market. A detailed picture of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape is provided, which ... Read More
-
Complicated Urinary Tract Infections - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Equine encephalitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024
... growth prospects across the Autoimmune pulmonary alveolar proteinosis (aPAP) market. A detailed picture of the Autoimmune pulmonary alveolar proteinosis (aPAP) pipeline landscape is provided, which includes the disease overview and Autoimmune pulmonary alveolar proteinosis (aPAP) ... Read More
-
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). Analysts at DelveInsight project that approximately 54% of the Total Diagnosed Prevalent Cases of Molybdenum Cofactor Deficiency Type ... Read More
-
Astigmatism - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Astigmatism treatment guidelines. The assessment part of the report embraces in-depth Astigmatism commercial assessment and clinical assessment of the Astigmatism pipeline products from the pre-clinical ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024
... pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive ... Read More
-
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024
... companies and 3+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Visceral Pain associated with GI disorders - Pipeline Insight, 2024
... development scenario and growth prospects across the Visceral Pain associated with GI disorders market. A detailed picture of the Visceral Pain associated with GI disorders pipeline landscape is provided, which includes the disease overview and ... Read More
-
Ocular Inflammation and Pain - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More